Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs. The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.
